Literature DB >> 30241863

Fucosylated chondroitin sulfate oligosaccharides from Isostichopus badionotus regulates lipid disorder in C57BL/6 mice fed a high-fat diet.

Shan Li1, Junhui Li1, Guizhu Mao1, Yaqin Hu1, Xingqian Ye1, Ding Tian1, Robert J Linhardt2, Shiguo Chen3.   

Abstract

Fucosylated chondroitin sulfate (fCS) and its depolymerized derivative (DfCS), prepared from sea cucumbers, are well-known for their anticoagulant activity. However, their other functional activities are poorly understood. Recently, we obtained fCS oligosaccharides from Isostichopus Badionotus by a modified controllable Fenton-system, named as DfCS-Ib. The functional activities of these oligosaccharides are still unclear. The present study investigated anti-hyperlipidemic activity of DfCS-Ib using a high-fat diet (HFD)-fed mice model. The results indicated that DfCS-Ib reduced obesity, hyperlipidemia, and inflammation caused by HFD. Meanwhile, DfCS-Ib increased the mRNA expression of PPARγ and decreased the mRNA expression of leptin, aP2, and F4/80 in fat tissue. Transcriptome analysis indicated that DfCS-Ib normalized the expressions of genes regulating lipid metabolism. Our results suggested that DfCS-Ib can alleviated lipid disorder by reducing lipid synthesis and promoting lipid lipidolysis. DfCS-Ib can act as a functional agent to regulate lipid disorder.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Fucosylated chondroitin sulfate oligosaccharide; High-fat diet; Lipid disorder; Sea cucumber; Transcriptome analysis

Mesh:

Substances:

Year:  2018        PMID: 30241863     DOI: 10.1016/j.carbpol.2018.08.020

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  4 in total

1.  Tilapia-Head Chondroitin Sulfate Protects against Nonalcoholic Fatty Liver Disease via Modulating the Gut-Liver Axis in High-Fat-Diet-Fed C57BL/6 Mice.

Authors:  Hui Yu; Xiangzhou Yi; Xia Gao; Jun Ji; Zhongyuan Liu; Guanghua Xia; Chuan Li; Xueying Zhang; Xuanri Shen
Journal:  Foods       Date:  2022-03-23

Review 2.  Sea cucumber-derived compounds for treatment of dyslipidemia: A review.

Authors:  Ping Lin; Nuo Shen; Fan Yin; Shou-Dong Guo
Journal:  Front Pharmacol       Date:  2022-09-14       Impact factor: 5.988

Review 3.  Collective Locomotion of Human Cells, Wound Healing and Their Control by Extracts and Isolated Compounds from Marine Invertebrates.

Authors:  Claudio Luparello; Manuela Mauro; Valentina Lazzara; Mirella Vazzana
Journal:  Molecules       Date:  2020-05-26       Impact factor: 4.411

4.  A Glycosaminoglycan-Rich Fraction from Sea Cucumber Isostichopus badionotus Has Potent Anti-Inflammatory Properties In Vitro and In Vivo.

Authors:  Leticia Olivera-Castillo; George Grant; Nuvia Kantún-Moreno; Hirian A Barrera-Pérez; Jorge Montero; Miguel A Olvera-Novoa; Leydi M Carrillo-Cocom; Juan J Acevedo; Cesar Puerto-Castillo; Victor May Solís; Juan A Pérez-Vega; Judit Gil-Zamorano; Enrique Hernández-Garibay; María A Fernández-Herrera; Mayra Pérez-Tapia; Oscar Medina-Contreras; Jairo R Villanueva-Toledo; Rossanna Rodriguez-Canul; Alberto Dávalos
Journal:  Nutrients       Date:  2020-06-06       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.